Scope
Reference
DAC134/0825PM
Description
The intended contract is for the supply of Enhertu (Trastuzumab Deruxtecan) 100mg powder for solution for infusion to Northern Health and Social Care Trust for the period of three years
Contract 1. ENHERTU (TRASTUZUMAB DERUXTECAN) 100MG POWDER FOR CONCENTRATE FOR SOLN FOR INFUSION VIAL
Supplier
Contract value
- £700,000 excluding VAT
- £840,000 including VAT
Above the relevant threshold
Award decision date
13 August 2025
Standstill period
- End: 26 August 2025
- 8 working days
Earliest date the contract will be signed
27 August 2025
Contract dates (estimated)
- 1 September 2025 to 31 August 2028
- 3 years
Main procurement category
Goods
CPV classifications
- 33600000 - Pharmaceutical products
Contract locations
- UKN - Northern Ireland
Procedure
Procedure type
Direct award
Supplier
NOVARTIS PHARMACEUTICALS UK LIMITED
- Companies House: 00119006
- Public Procurement Organisation Number: PJTX-5182-QVLR
2nd Floor, The Westworks Building White City Place
London
W12 7FQ
United Kingdom
Email: commercial.pricing@novartis.com
Website: https://www.novartis.com/uk-en/
Region: UKI33 - Kensington & Chelsea and Hammersmith & Fulham
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Supported employment provider: No
Public service mutual: No
Contract 1. ENHERTU (TRASTUZUMAB DERUXTECAN) 100MG POWDER FOR CONCENTRATE FOR SOLN FOR INFUSION VIAL
Contracting authority
Northern Health And Social Care Trust
- Public Procurement Organisation Number: PBRP-6676-CQZY
Brettan Hall, Antrim Area Hospital, Bush Road
Antrim
BT41 2RL
United Kingdom
Region: UKN0D - Antrim and Newtownabbey
Organisation type: Public authority - central government
Devolved regulations that apply: Northern Ireland